Last news
Strategic Partnership | Sanyou Bio and KanryBio Forge Partnership to Co-Develop Key Reagents and Products for Biomarker Assay Kits

Strategic Partnership | Sanyou Bio and KanryBio Forge Partnership to Co-Develop Key Reagents and Products for Biomarker Assay Kits

SHANGHAI, Dec. 12, 2025 /PRNewswire/ -- On December 10, 2025, Sanyou Biopharmaceuticals (Shanghai) Co., Ltd. ("Sanyou Bio") and Wenzhou KanryBio Biotech Co., Ltd. ("KanryBio") announced a strategic collaboration agreement. The partnership will focus...

United Imaging Intelligence at RSNA 2025: Reshaping Medicine with AI Agents

United Imaging Intelligence at RSNA 2025: Reshaping Medicine with AI Agents

SHANGHAI, Dec. 12, 2025 /PRNewswire/ -- Under the theme "Imaging the Individual", RSNA 2025 challenged the radiology community to push into new frontiers and close the gap between personalized care and global health disparities. This year, United...

NYSE Content Advisory: Pre-Market Update + Chipotle Mexican Grill Rings NYSE Bell Amid Expansion

NYSE Content Advisory: Pre-Market Update + Chipotle Mexican Grill Rings NYSE Bell Amid Expansion

NEW YORK, Dec. 12, 2025 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins. NYSE Content...

Global Attention: POGMENT Biomimetic Collagen "Stable Triple-Helix Breakthrough" --Unconventional and Astonishing

Global Attention: POGMENT Biomimetic Collagen "Stable Triple-Helix Breakthrough" --Unconventional and Astonishing

— LivingPhoenix Forum's 12 Conference Presentation Ignite International and Domestic Academia, Hailed by Academicians as the "iPhone Moment for Extracellular Matrix Research" CHENGDU, China, Dec. 12, 2025 /PRNewswire/ -- LivingPhoenix Regenerative...

Ractigen Therapeutics Doses First Patient in IIT Study of RAG-18, a Potential Game-Changing saRNA Therapeutic for Duchenne Muscular Dystrophy

Ractigen Therapeutics Doses First Patient in IIT Study of RAG-18, a Potential Game-Changing saRNA Therapeutic for Duchenne Muscular Dystrophy

NANTONG, China, Dec. 12, 2025 /PRNewswire/ -- Ractigen Therapeutics, a pioneering developer of small activating RNA (saRNA) therapeutics, today announced the successful dosing of the first patient in its investigator-initiated trial (IIT) of RAG-18...

OneOne Announces Strategic Collaboration with CoffeeBot to Elevate On-Ground User Engagement Across Malaysia

OneOne Announces Strategic Collaboration with CoffeeBot to Elevate On-Ground User Engagement Across Malaysia

KUALA LUMPUR, Malaysia, Dec. 12, 2025 /PRNewswire/ -- One of the key platforms from ONEVERSE™, OneOne™, a leading Southeast Asian fintech and digital engagement company, is excited to announce a new collaboration with CoffeeBot Malaysia, the...

Plume Appoints Lorie Boyd as Chief People Officer

Plume Appoints Lorie Boyd as Chief People Officer

Boyd brings deep HR and workforce management experience from Turo and Zendesk to help Plume scale through next phase of global growth PALO ALTO, Calif., Dec. 12, 2025 /PRNewswire/ -- Plume, a leader in cloud-managed Wi-Fi, security, and smart home...

Robo.ai Inc. Reaches a $180 Million Financing Agreement with ATW Partners

Robo.ai Inc. Reaches a $180 Million Financing Agreement with ATW Partners

DUBAI, UAE, Dec. 12, 2025 /PRNewswire/ -- Robo.ai Inc. (NASDAQ: AIIO), a technology platform dedicated to "AI, Smart Device and Smart Asset", today announced that it has entered into definitive agreements with ATW Partners (www.atwpartners.com) for...

menu
menu